Latest European Medicines Agency Stories
- HETLIOZ®, a circadian regulator, is the first and only product to receive a recommendation for approval for Non-24 in the European Union WASHINGTON, April 24, 2015 /PRNewswire/
- Hospira calls for continued support of extrapolation principle to help drive increased patient access to life-saving biologic medicines - LONDON, April 24, 2015 /PRNewswire/ --
The Clinical Data Interchange Standards Consortium (CDISC) is pleased to announce the participation of high-level representatives from the U.S.
LA JOLLA, Calif., March 25, 2015 /PRNewswire/ -- Regulus Therapeutics Inc.
CALGARY, March 25, 2015 /PRNewswire/ - Oncolytics Biotech(®) Inc.
BANGALORE, March 23, 2015 /PRNewswire/ -- - The First Stem Cell Drug Based on Pooling Technology to be Granted ATMP Classification - A New Treatment Which
NESS ZIONA, Israel, March 16, 2015 /PRNewswire/ -- - Recognition of the unmet medical need and high therapeutic potential of ImMucin in Multiple
If authorized, SB2 will be marketed in Europe by Biogen Idec INCHEON, South Korea, March 13, 2015 /PRNewswire/ -- Samsung Bioepis Co., Ltd., today announced that the Marketing Authorization
MONT-SAINT-GUIBERT, Belgium, March 2, 2015 /PRNewswire/ -- Cardio3 BioSciences (C3BS) (Euronext Brussels and Paris: CARD), a leader in the discovery and development of specialized cell
STOCKLEY PARK, London, March 2, 2015 /PRNewswire/ -- Taiho Pharma Europe Ltd., a subsidiary of Japan based Taiho
- A person in a secondary role, specifically the second most important character (after the protagonist).